The fate of 1,3,5-tri(3,5-di-tert.-butyl-4-hydroxybenzyl)-2,4,6-trimethylbenzene (Ionox 330) in rats fed the compound over a prolonged period.
D000273:Adipose Tissue / Q000378:metabolism; D000535:Aluminum; D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage*; D001593:Benzyl Compounds / Q000008:administration & dosage / Q000378:metabolism*; D001692:Biological Transport; D002250:Carbon Radioisotopes; D002845:Chromatography; D002855:Chromatography, Thin Layer; D004064:Digestive System / Q000378:metabolism*; D005243:Feces / Q000032:analysis; D005260:Female; D008099:Liver / Q000378:metabolism; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D013058:Mass Spectrometry; D010084:Oxidation-Reduction; D010636:Phenols / Q000008:administration & dosage / Q000378:metabolism*; D051381:Rats; D013055:Spectrophotometry, Infrared; D013056:Spectrophotometry, Ultraviolet; D013329:Structure-Activity Relationship; D013997:Time Factors
D000975:Antioxidants; D001593:Benzyl Compounds; D002250:Carbon Radioisotopes; D010636:Phenols; D000535:Aluminum